Browse our wide selection of products for your research needs
| CAT.NO. | Product Name | Physical Specs | Size | Inquiry |
|---|---|---|---|---|
| LNP-001 | Cationic lipid nanoparticles | 10 mg | Inquiry | |
| 20 mg | Inquiry | |||
| 50 mg | Inquiry | |||
| LNP-002 | Doxorubicin hydrochloride lipid nanoparticles | 10 mg | Inquiry | |
| 20 mg | Inquiry | |||
| 50 mg | Inquiry | |||
| LNP-004 | Exosome-like lipid nanoparticles | 10 mg | Inquiry | |
| 20 mg | Inquiry | |||
| 50 mg | Inquiry | |||
| LNP-005 | PEGylated lipid nanoparticles with phospholipid-cholesterol components | 10 mg | Inquiry | |
| 20 mg | Inquiry | |||
| 50 mg | Inquiry | |||
| LNP-006 | DOTAP-DOPE lipid nanoparticle | 10 mg | Inquiry | |
| 20 mg | Inquiry | |||
| 50 mg | Inquiry | |||
| LNP-007 | Adavosertib lipid nanoparticle | 10 mg | Inquiry | |
| 20 mg | Inquiry | |||
| 50 mg | Inquiry | |||
| LNP-008 | Mirdametinib (PD0325901)lipid nanoparticle | 10 mg | Inquiry | |
| 20 mg | Inquiry | |||
| 50 mg | Inquiry | |||
| LNP-009 | DT-061 (SMAP)lipid nanoparticle | 10 mg | Inquiry | |
| 20 mg | Inquiry | |||
| 50 mg | Inquiry | |||
| LNP-010 | Tanspiramycin (17-AAG)lipid nanoparticle | 10 mg | Inquiry | |
| 20 mg | Inquiry | |||
| 50 mg | Inquiry | |||
| LNP-011 | Nexturastat A lipid nanoparticle | 10 mg | Inquiry | |
| 20 mg | Inquiry | |||
| 50 mg | Inquiry |